leadf
logo-loader
viewWillow Biosciences Inc.

Willow Biosciences plans to use proprietary yeast strain to produce THC for Cannabis 2.0

Willow Biosciences (TSE: WLLO- OTCQX: CANSF) CEO Trevor Peters joined Steve Darling from Proactive with news the company has announced plans to commercially launch their proprietary yeast strain for the production of THC for Cannabis 2.0.

Peters talks about the research that has gone into this and that it’s odourless and flavourless attributes will make a strong core ingredient to produce products with. Peters also shares the timeline for this product to be available.

Quick facts: Willow Biosciences Inc.

Price: 1.39 CAD

TSX:WLLW
Market: TSX
Market Cap: $171.34 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Willow Biosciences Inc. named herein, including the promotion by the Company of Willow Biosciences Inc. in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Willow BioSciences picks CMO to begin production of yeast-based CBG six...

Willows BioSciences (TSX: WLLW- OTCQX: CANSF) CEO Trevor Peters joined Steve Darling from Proactive with news the company has selected its commercial manufacturing organization to produce its first CBG multi-kilogram run scheduled in Q1 2021. Peters telling Proactive this move is 6 months...

on 12/16/2020

2 min read